Publication Name	World Journal of Diabetes
Manuscript ID	16086
Country

Received	2014-12-25 08:41
Peer-Review Started	2014-12-26 08:13
To Make the First Decision	2015-02-07 14:51
Return for Revision	2015-02-10 10:26
Revised	2015-02-20 08:35
Second Decision	2015-03-16 18:07
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2015-04-07 16:02
Articles in Press	2015-04-07 16:03
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-05-28 18:23
Publish the Manuscript Online	2015-06-19 17:20

ISSN	1948-9358 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Critical Care Medicine
Manuscript Type	Review
Article Title	Management of critically ill patients with type 2 diabetes: The need for personalised therapy
Manuscript Source	Invited Manuscript
All Author List	Palash Kar, Karen L Jones, Michael Horowitz and Adam M Deane
Funding Agency and Grant Number
Corresponding Author	Dr. Palash Kar, Intensive Care Unit, Level 4, Emergency Services Building, Royal Adelaide Hospital, North Terrace, Adelaide, South Australia 5000, Australia. p_kar@hotmail.com
Key Words	Diabetes; Critically ill; Intensive care; Management; Personalised therapy
Core Tip	With diabetes increasing in prevalence, the optimal management of glycaemia in critically ill patients with pre-existing diabetes remains unknown. Recent data has highlighted therapeutic uncertainties specific to these patients with suggestions that targeted blood glucose concentrations may benefit from consideration of a patient’s premorbid glucose state. In patients with uncontrolled type 2 diabetes, it may be safer to target blood glucose concentrations between 10-14 mmol/L, however definitive studies of critically ill patients with poorly controlled diabetes are required. In contrast, in patients with CIAH, or those with well-controlled diabetes (HbA1c < 7.0) have data supporting a more conservative target (6-10 mmol/L).
Publish Date	2015-06-19 17:20
Citation	Kar P, Jones KL, Horowitz M, Deane AM. Management of critically ill patients with type 2 diabetes: The need for personalised therapy. World J Diabetes 2015; 6(5): 693-706
URL	http://www.wjgnet.com/1948-9358/full/v6/i5/693.htm
DOI	http://dx.doi.org/10.4239/wjd.v6.i5.693

Full Article (PDF)	WJD-6-693.pdf
Manuscript File	16086-Review.docx
Answering Reviewers	16086-Answering reviewers.pdf
Audio Core Tip	16086-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	16086-Conflict-of-interest statement.pdf
Copyright License Agreement	16086-Copyright assignment.pdf
Peer-review Report	16086-Peer-review(s).pdf
Scientific Misconduct Check	16086-Scientific misconduct check.pdf
Scientific Editor Work List	16086-Scientific editor work list.pdf